AF LoBuglio

2.9k citations
45 papers · 2.4k indexed · 2 hit papers · h-index 21

Impact in

  • Immunology top 5%
    • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses
    • Lymphoma Diagnosis and Treatment

Papers in

    • Neutrophil, Myeloperoxidase and Oxidative Mechanisms 9
    • Platelet Disorders and Treatments 7
    • Blood groups and transfusion 7

AF LoBuglio

43 papers receiving 2.2k citations

Hit Papers

Treatment of Patients With Low-Grade B-Cell Lymphoma With the Combination of Chimeric Anti-CD20 Monoclonal Antibody and CHOP Chemotherapy 1999 · 672 citations
6721981202619962011200400600

Peers

AF LoBuglio
Comparison fields: 5 of 118
  • Immunology 836
  • Pathology and Forensic Medicine 692
  • Genetics 343
  • Oncology 597
  • Hematology 240
Replace R. Osieka with:
R. Osieka Germany
Hisanori Uehara Japan
Christopher Frantz United States
Kiyohiko Hatake Japan
Gerhard Seitz Germany
Sumio Sakamaki Japan
Akari Suzuki Japan
Carl E. Freter United States
Hannes Hentze Singapore
Teresa A. Lehman United States
AF LoBuglio relative to R. Osieka Germany R. Osieka's profile →
Citations per field
00.5×2.8×
R. Osieka · 1×
Citations per year

Countries citing papers authored by AF LoBuglio

Since Specialization
Citations

This map shows the geographic impact of AF LoBuglio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AF LoBuglio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AF LoBuglio more than expected).

Fields of papers citing papers by AF LoBuglio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by AF LoBuglio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AF LoBuglio. The network helps show where AF LoBuglio may publish in the future.

Co-authors

The 25 scholars most cited alongside AF LoBuglio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with AF LoBuglio Line = papers co-authored together AF LoBuglio links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20093
2
Treatment of human breast cancer xenografts with monoclonal antibody against DR5 with or without chemotherapy inhibits tumor growth in nude mice
20022
3 200154
4
Phase I study of 90Y-CC49 monoclonal antibody therapy in patients with advanced non-small cell lung cancer
20002
5
Phase II study of dual 131I-labeled monoclonal antibody therapy with interferon in patients with metastatic colorectal cancer.
199649
6
Phase II trial of murine monoclonal antibody D612 combined with recombinant human monocyte colony-stimulating factor (rhM-CSF) in patients with metastatic gastrointestinal cancer.
19958
7 199337
8 199315
9 199014
10 198853
11 198872
12 198811
13 198746
14 198756
15 19872
16
Immunoperoxidase staining of early human melanoma colonies with monoclonal antibodies. A new method for in vitro antigenic-morphologic correlation.
19843
17
Role of hydrogen peroxide in neutrophil-mediated destruction of cultured endothelial cells.
Hit paper breakdown →
1981497
18 19808
19 197829
20
Transfer-factor therapy of malignancy.
19749

About AF LoBuglio

AF LoBuglio is a scholar working on Immunology, Hematology, Radiology, Nuclear Medicine and Imaging, Genetics and Oncology, having authored 45 papers that have together received 2.4k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (10 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (9 papers), Platelet Disorders and Treatments (7 papers), Blood groups and transfusion (7 papers), Erythrocyte Function and Pathophysiology (5 papers), Cancer Treatment and Pharmacology (5 papers), Vitamin C and Antioxidants Research (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). The work is most often cited by research in Immunology (836 citations), Pathology and Forensic Medicine (692 citations), Genetics (343 citations), Oncology (597 citations) and Hematology (240 citations). AF LoBuglio has collaborated with scholars based in United States and Russia. Frequent co-authors include Stephen J. Weiss, Adam Slivka, John K. Young, Mansoor N. Saleh, SJ Weiss, Leo I. Gordon, Christine A. White, M. S. Czuczman, A.J. Grillo-López and C. Jonas. Their work appears in journals such as Blood, Journal of Clinical Oncology, The Journal of Immunology, JNCI Journal of the National Cancer Institute and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026